XML 20 R5.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Common Stock in Treasury
Non- controlling Interest
Common stock, beginning balance (in shares) at Sep. 30, 2024   124,376,000          
Beginning balance at Sep. 30, 2024 $ 191,063 $ 217 $ 1,806,000 $ 4,750 $ (1,625,523)   $ 5,619
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 15,209   15,209        
Exercise of stock options (in shares)   70,000          
Exercise of stock options 634   634        
Common stock - restricted stock units vesting (in shares)   209,000          
Issuance of pre-funded warrants (in shares)   917,000          
Issuance of pre-funded warrants 25,000 $ 1 24,999        
Foreign currency translation adjustments (106)     (106)      
Unrealized gains (losses) on available-for-sale securities (507)     (507)      
Net income (loss) (175,218)       (173,085)   (2,133)
Common stock, ending balance (in shares) at Dec. 31, 2024   125,572,000          
Ending balance at Dec. 31, 2024 $ 56,075 $ 218 1,846,842 4,137 (1,798,608)   3,486
Common stock, beginning balance (in shares) at Sep. 30, 2025 135,702,000 138,363,000          
Beginning balance at Sep. 30, 2025 $ 503,416 $ 231 2,139,725 6,443 (1,627,154) $ (53,193) 37,364
Treasury stock, beginning balance (in shares) at Sep. 30, 2025 (2,661,000)         (2,661,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation $ 19,371   19,371        
Exercise of stock options (in shares) 296,682 296,000          
Exercise of stock options $ 5,098   5,098        
Common stock - restricted stock units vesting (in shares)   704,000          
Common stock - restricted stock units vesting 2 $ 1 1        
Issuance of common stock under at-the-market offering, net of issuance costs (in shares)   689,000          
Issuance of common stock under at-the-market offering, net of issuance costs 46,832 $ 1 46,831        
Foreign currency translation adjustments 110     110      
Unrealized gains (losses) on available-for-sale securities 146     146      
Dividends declared by variable interest entity to noncontrolling shareholders (40,520)           (40,520)
Net income (loss) $ 28,242       30,811   (2,569)
Common stock, ending balance (in shares) at Dec. 31, 2025 137,391,000 140,052,000          
Ending balance at Dec. 31, 2025 $ 562,697 $ 233 $ 2,211,026 $ 6,699 $ (1,596,343) $ (53,193) $ (5,725)
Treasury stock, ending balance (in shares) at Dec. 31, 2025 (2,661,000)         (2,661,000)